NCT01383954View on ClinicalTrials.gov

The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2012

Conditions
Knee Osteoarthritis
Interventions
DRUG

Diclofenac Gel

Diclofenac gel 4 grams (g) applied topically 4 times daily (QID) to the affected knee(s) for up to 4 weeks. Participants took a maximum dosage of 32 g/day.

Trial Locations (1)

02467

Brigham and Women's Hospital, Chestnut Hill

Sponsors

Collaborators (1)

Endo Pharmaceuticals
All Listed Sponsors
collaborator

Endo Pharmaceuticals

INDUSTRY

lead

Brigham and Women's Hospital

OTHER